论文部分内容阅读
在日前召开的第三届全国重型肝病及人工肝血液净化学术年会上,专家认为应对肝移植适应症进行理性思考。据统计,目前我国年肝移植例数已超过2000例,国内肝移植总数已超过7000例,其中肝癌肝移植占到总数的30%～60%。但是,肝癌肝移植的预后效果则欠佳——美国肝癌肝移植的5年生存率为43%,低于整体移植人群75%的5年生存率。国内
At the 3rd National Academic Conference on Severe Liver Disease and Artificial Liver Blood Purification held recently, experts believe that there should be rational thinking about the indications for liver transplantation. According to statistics, at present, the number of cases of liver transplantation in China has exceeded 2000 cases. The total number of liver transplants in China has exceeded 7000 cases, of which liver cancer liver transplantation accounted for 30% to 60% of the total. However, the prognosis of hepatocellular carcinoma liver transplantation is poor. The 5-year survival rate of liver transplantation in the United States is 43%, which is lower than the 75% 5-year survival rate of the overall transplant population. domestic